After Hours
The risks associated with pre-market and after-hours trading may be slightly higher than the regular market hours. The reason is that extended-hours trading may result in wider spreads for particular security due to lower liquidity and higher volatility as issuers often announce critical financial information outside regular trading hours.
Stocks Info
Vertex Pharmaceuticals, Inc is listed on the NASDAQ as a member of the Healthcare sector and is a part of the Biotechnology industry. The current market capitalization of Vertex Pharmaceuticals, Inc is $118.84B. A total of 1.33 million shares were traded on the day, compared to an average of 1.42M shares.
In the most recent transaction, Tatsis Ourania sold 4,500 shares of VRTX for 474.99 per share on Jan 07 ’26. After the transaction, the EVP, Chief Reg. & Quality Off. now owns 42,293 company shares. In a previous transaction on Jan 06 ’26, WAGNER CHARLES F JR sold 9,532 shares at 461.00 per share. VRTX shares that EVP, CO & FO owns now total 37,725.
Among the insiders who bought shares, Tatsis Ourania acquired of 4,500 shares on Jan 07 ’26 at a per-share price of $474.99. In another insider transaction, WAGNER CHARLES F JR bought 9,532 shares at $461.00 per share on Jan 06 ’26.
Though price targets are rarely accurate, they can exert some influence from time to time and were often accepted as valuable by the market. In terms of 52-week highs and lows, VRTX has a high of $519.68 and a low of $362.50.
As of this writing, VRTX has an earnings estimate of $5.14 per share for the current quarter. EPS was calculated based on a consensus of 22.0 estimates, with a high estimate of $5.71 per share and a lower estimate of $4.46. The company reported an EPS of $3.98 in the last quarter
Balance Sheet Annually/Quarterly
A balance sheet is a report that shows the company’s assets and liabilities. In addition, it shows how much equity investors have invested in the company. Investors can determine the company’s prospects by calculating its financial ratios based on this information. VRTX’s latest balance sheet shows that the firm has $7.52B in Cash & Short Term Investments as of fiscal 2021. There were $967.40M in debt and $2.14B in liabilities at the time. Its Book Value Per Share was $68.20, while its Total Shareholder’s Equity was $10.10B.
Analysts Opinion
It may be riskier to trade before market opening and after market closing than during regular market hours. Since issuers often announce critical financial information outside regular trading hours. Extended-hours trading may result in wider spreads for particular securities due to lower liquidity and higher volatility. Currently, 0 analysts are providing their opinions on the stock.
